CSE bulletin 2024-0235

Entheon Biomedical Corp. has consolidated its issued and outstanding common shares on the basis of one postconsolidated common share for every 10 preconsolidated common shares.

As a result, the outstanding shares of the company will be reduced to approximately 5,908,926 common shares.

The name and symbol will not change.

Please note that all open orders will be cancelled at the close of business on Feb. 29, 2024. Dealers are reminded to re-enter their orders taking into account the share consolidation.

Trading on a consolidated basis:  March 1, 2024

Record date:  March 4, 2024

Anticipated payment date:  March 1, 2024

Symbol:  ENBI

New Cusip No.:  29383X 20 2

New ISIN:  CA 29383X 20 2 3

Old Cusip No.:  29383X 10 3

Old ISIN:  CA 29383X 10 3 3